Journals / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 2

Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study

Pages
180–186
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Areas under the receiving-operator characteristics curve (AUC) are reported.Results: Overall, 631 patients were included.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: The albumin-bilirubin (ALBI) score is a new model for assessing the severity of liver dysfunction.
📊
Key Findings & Data:In the present study, we aimed to retrospectively compare the performance of ALBI with Child-Pugh and the model for end-stage liver disease (MELD) scores for predicting the in-hospital mortality of acute gastrointestinal bleeding (AUGIB) in liver cirrhosis.Materials and Methods: All cirrhotic patients with AUGIB were eligible, provided they had the data needed to determine the ALBI score.
💡
Conclusion & Impact:Areas under the receiving-operator characteristics curve (AUC) are reported.Results: Overall, 631 patients were included.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: The albumin-bilirubin (ALBI) score is a new model for assessing the severity of liver dysfunction. In the present study, we aimed to retrospectively compare the performance of ALBI with Child-Pugh and the model for end-stage liver disease (MELD) scores for predicting the in-hospital mortality of acute gastrointestinal bleeding (AUGIB) in liver cirrhosis.Materials and Methods: All cirrhotic patients with AUGIB were eligible, provided they had the data needed to determine the ALBI score. Areas under the receiving-operator characteristics curve (AUC) are reported.Results: Overall, 631 patients were included. In all the included patients, the AUC of the ALBI, Child-Pugh, and MELD scores were 0.808, 0.785 (p=0.5831), and 0.787 (p=0.7033), respectively. In patients with only hepatitis B virus-related liver cirrhosis, the AUC of the ALBI, Child-Pugh, and MELD scores were 0.865, 0.836 (p=0.6064), and 0.818 (p=0.6399), respectively. In patients with only alcohol-related liver cirrhosis, the AUC of the ALBI, ChildPugh, and MELD scores were 0.869, 0.860 (p=0.9003), and 0.801 (p=0.5548), respectively. In patients treated with endoscopic therapy for AUGIB, the AUC of the ALBI, Child-Pugh, and MELD scores were 0.873, 0.884 (p=0.7898), and 0.834 (p=0.5531), respectively.Conclusion: The prognostic performance of the ALBI score was comparable with that of the Child-Pugh and MELD scores for predicting the in-hospital mortality of AUGIB in liver cirrhosis

🔖

Cite This Article

ZOU, D., Qİ, X., ZHU, C., NİNG, Z., HOU, F., ZHAO, J., PENG, Y., LI, J., DENG, H., GUO, X. (2016). Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 2, 180–186. https://ajindex.com/articles/410741

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new ev- idence-based approach-the ALBI grade. J Clin Oncol 2015; 33: 550-8. [CrossRef] Knox JJ. Addressing the interplay of liver disease and hepatocel- lular carcinoma on patient survival: the ALBI scoring model. J Clin Oncol 2015; 33: 529-31. [CrossRef] Ogasawara S, Chiba T, Ooka Y, et al. Liver function assessment ac- cording to the Albumin-Bilirubin (ALBI) grade in sorafenib-treat- ed patients with advanced hepatocellular carcinoma. Invest New Drugs 2015. [CrossRef] Chan AW, Chan RC, Wong GL, et al. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score. J Gastroen- terol Hepatol 2015; 30: 1391-6. [CrossRef] Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85.
  2. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805. [CrossRef] Peng Y, Qi X, Dai J, et al. Child-Pugh versus MELD score for pre- dicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med 2015; 8: 751-7.
  3. Chalasani N, Kahi C, Francois F, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002; 35: 1282-4. [CrossRef] Zhu C, Qi X, Li H, et al. Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study. Int J Clin Exp Med 2015; 8: 5989-98.
  4. Qi X, Peng Y, Li H, et al. Diabetes is associated with an increased risk of in-hospital mortality in liver cirrhosis with acute upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol 2015; 27: 476-7. [CrossRef] Deng H, Qi X, Peng Y, et al. Diagnostic accuracy of APRI, AAR, FIB- 4, FI, and King scores for diagnosis of esophageal varices in liver cirrhosis: A retrospective study. Med Sci Monit 2015; 21: 3961-77.
  5. Li J, Qi X, Deng H, et al. Association of conventional haemostasis and coagulation tests with the risk of acute upper gastrointesti- nal bleeding in liver cirrhosis: a retrospective study. Gastroenterol Rep (Oxf ) 2015. [CrossRef] Dai J, Qi X, Peng Y, et al. Association between D-dimer level and portal venous system thrombosis in liver cirrhosis: a retrospective observational study. Int J Clin Exp Med 2015; 8: 15296-301. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on m